XCYTE THERAPIES INC
S-1, EX-27.1, 2000-12-22
Previous: XCYTE THERAPIES INC, S-1, EX-23.2, 2000-12-22
Next: VERTICAL SOLUTIONS INC, 10SB12G, 2000-12-22



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                             124
<SECURITIES>                                     7,239
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 7,700
<PP&E>                                           2,427
<DEPRECIATION>                                     603
<TOTAL-ASSETS>                                  10,055
<CURRENT-LIABILITIES>                            1,600
<BONDS>                                              0
                           23,405
                                          0
<COMMON>                                             6
<OTHER-SE>                                    (15,804)
<TOTAL-LIABILITY-AND-EQUITY>                    10,055
<SALES>                                              0
<TOTAL-REVENUES>                                    16
<CGS>                                                0
<TOTAL-COSTS>                                    7,125
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 206
<INCOME-PRETAX>                                (6,947)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (6,947)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,947)
<EPS-BASIC>                                     (1.15)
<EPS-DILUTED>                                   (1.15)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission